Back

New therapies for ATTR-CM, new patient expectations

17 May 2025 (12:55 - 13:05)
Organised by: Logo
Congress Presentation Part of: ATTRibutes of change: advances in treating and monitoring ATTR-CM Cardiomyopathies HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Professor Marianna Fontana

University College London, London (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Welcome and introduction
Professor A. Ristic (Belgrade, RS)
Presentation thumbnail
From suspicion to ATTR-CM diagnosis: How do we streamline?
Doctor P. Garcia-Pavia (Majadahonda, ES)
Presentation thumbnail
Linking serum TTR to patient outcomes in ATTR-CM
Doctor L. Obici (Pavia, IT)
Presentation thumbnail
Practical insights from ATTR-CM patient cases
Professor C. Tschoepe (Berlin, DE)
Presentation thumbnail
Panel discussion and Q&A

Access the full session

Session thumbnail
ATTRibutes of change: advances in treating and monitoring ATTR-CM
Video

The Event

Event poster

Heart Failure 2025

17 May 2025 12:55 CET
You may be interested in
thumbnail
Congress Session
When to look for amyloidosis
18 May 2025
thumbnail
Congress Presentation
Exploring the wealth of long-term data for ATTR-CM management​
31 August 2025
thumbnail
Congress Session
Clinical and real-world data in ATTR cardiomyopathy: reviewing their place in daily practice
19 May 2025
thumbnail
Congress Presentation
Clinical presentation and treatment landscape of patients with transthyretin amyloidosis with cardiomyopathy: a real-world study in five European countries and Japan
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources